203 related articles for article (PubMed ID: 23046293)
41. Is brief psychodynamic psychotherapy in primary fibromyalgia syndrome with concurrent depression an effective treatment? A randomized controlled trial.
Scheidt CE; Waller E; Endorf K; Schmidt S; König R; Zeeck A; Joos A; Lacour M
Gen Hosp Psychiatry; 2013; 35(2):160-7. PubMed ID: 23218844
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A
Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576
[TBL] [Abstract][Full Text] [Related]
43. Group treatment of fibromyalgia: a 6 month outpatient program.
Bennett RM; Burckhardt CS; Clark SR; O'Reilly CA; Wiens AN; Campbell SM
J Rheumatol; 1996 Mar; 23(3):521-8. PubMed ID: 8832996
[TBL] [Abstract][Full Text] [Related]
44. Treatment of fibromyalgia at the Maharishi Ayurveda Health Centre in Norway. A six-month follow-up study.
Rasmussen LB; Mikkelsen K; Haugen M; Pripp AH; Førre ØT
Clin Exp Rheumatol; 2009; 27(5 Suppl 56):S46-50. PubMed ID: 20074439
[TBL] [Abstract][Full Text] [Related]
45. Ozone therapy in 65 patients with fibromyalgia: an effective therapy.
Tirelli U; Cirrito C; Pavanello M; Piasentin C; Lleshi A; Taibi R
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1786-1788. PubMed ID: 30840304
[TBL] [Abstract][Full Text] [Related]
46. Pain, quality of life, self perception of health and depression in patients with fibromyalgia, submited to hydrokinesiotherapy.
Letieri RV; Furtado GE; Letieri M; Góes SM; Pinheiro CJ; Veronez SO; Magri AM; Dantas EM
Rev Bras Reumatol; 2013; 53(6):494-500. PubMed ID: 24477728
[TBL] [Abstract][Full Text] [Related]
47. Balneotherapy in fibromyalgia: a single blind randomized controlled clinical study.
Ozkurt S; Dönmez A; Zeki Karagülle M; Uzunoğlu E; Turan M; Erdoğan N
Rheumatol Int; 2012 Jul; 32(7):1949-54. PubMed ID: 21461716
[TBL] [Abstract][Full Text] [Related]
48. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
Holman AJ; Myers RR
Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
[TBL] [Abstract][Full Text] [Related]
49. Effects of yoga and the addition of Tui Na in patients with fibromyalgia.
da Silva GD; Lorenzi-Filho G; Lage LV
J Altern Complement Med; 2007 Dec; 13(10):1107-13. PubMed ID: 18166122
[TBL] [Abstract][Full Text] [Related]
50. The impact of mood, anxiety, and sleep disorders on fibromyalgia.
Consoli G; Marazziti D; Ciapparelli A; Bazzichi L; Massimetti G; Giacomelli C; Rossi A; Bombardieri S; Dell'Osso L
Compr Psychiatry; 2012 Oct; 53(7):962-7. PubMed ID: 22534032
[TBL] [Abstract][Full Text] [Related]
51. Agomelatine for the treatment of patients with fibromyalgia and depressive symptomatology: an uncontrolled, 12-week, pilot study.
Calandre EP; Slim M; Garcia-Leiva JM; Rodriguez-Lopez CM; Torres P; Rico-Villademoros F
Pharmacopsychiatry; 2014 Mar; 47(2):67-72. PubMed ID: 24549860
[TBL] [Abstract][Full Text] [Related]
52. History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.
Pae CU; Masand PS; Marks DM; Krulewicz S; Han C; Peindl K; Mannelli P; Patkar AA
World J Biol Psychiatry; 2009; 10(4 Pt 2):435-41. PubMed ID: 19382010
[TBL] [Abstract][Full Text] [Related]
53. rTMS in fibromyalgia: a randomized trial evaluating QoL and its brain metabolic substrate.
Boyer L; Dousset A; Roussel P; Dossetto N; Cammilleri S; Piano V; Khalfa S; Mundler O; Donnet A; Guedj E
Neurology; 2014 Apr; 82(14):1231-8. PubMed ID: 24670891
[TBL] [Abstract][Full Text] [Related]
54. Use of ziprasidone in patients with fibromyalgia: a case series.
Calandre EP; Hidalgo J; Rico-Villademoros F
Rheumatol Int; 2007 Mar; 27(5):473-6. PubMed ID: 17039363
[TBL] [Abstract][Full Text] [Related]
55. Characteristics of patients with fibromyalgia in France and Germany.
Perrot S; Winkelmann A; Dukes E; Xu X; Schaefer C; Ryan K; Chandran A; Sadosky A; Zlateva G
Int J Clin Pract; 2010 Jul; 64(8):1100-8. PubMed ID: 20497264
[TBL] [Abstract][Full Text] [Related]
56. Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
Arnold LM; Zhang S; Pangallo BA
Clin J Pain; 2012; 28(9):775-81. PubMed ID: 22971669
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of the interdisciplinary PSYMEPHY treatment on patients with fibromyalgia: a randomized control trial.
Martín J; Torre F; Aguirre U; González N; Padierna A; Matellanes B; Quintana JM
Pain Med; 2014 Apr; 15(4):682-91. PubMed ID: 24576148
[TBL] [Abstract][Full Text] [Related]
58. Long-term evaluation of opioid treatment in fibromyalgia.
Peng X; Robinson RL; Mease P; Kroenke K; Williams DA; Chen Y; Faries D; Wohlreich M; McCarberg B; Hann D
Clin J Pain; 2015 Jan; 31(1):7-13. PubMed ID: 24480913
[TBL] [Abstract][Full Text] [Related]
59. Cognitive-behavioral therapy for insomnia improves attentional function in fibromyalgia syndrome: a pilot, randomized controlled trial.
Miró E; Lupiáñez J; Martínez MP; Sánchez AI; Díaz-Piedra C; Guzmán MA; Buela-Casal G
J Health Psychol; 2011 Jul; 16(5):770-82. PubMed ID: 21346020
[TBL] [Abstract][Full Text] [Related]
60. Benefit of Qigong exercise in patients with fibromyalgia: a pilot study.
Liu W; Zahner L; Cornell M; Le T; Ratner J; Wang Y; Pasnoor M; Dimachkie M; Barohn R
Int J Neurosci; 2012 Nov; 122(11):657-64. PubMed ID: 22784212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
